📈 Revenue History (16 Quarters)
🧮 IDXG Revenue Breakdown
Understanding Revenue
Revenue, also called sales or the "top line," represents the total income a company generates from its business activities before any costs are deducted. For IDXG, the trailing twelve month revenue is $36.1M.
Why Revenue Matters
Revenue is the foundation of all financial analysis. A company cannot have sustainable profits without revenue, and revenue growth often drives stock price appreciation. However, revenue alone doesn't tell the full story - it must be analyzed alongside profitability metrics.
IDXG's revenue growth rate of 6.65% (based on log-linear regression of 16 quarters) indicates modest positive growth.
Revenue vs Profitability Metrics
Free Cash Flow: $4.5M →
The cash remaining after capital expenditures. High revenue with negative FCF may indicate heavy reinvestment or poor cash conversion.
Owner Earnings: $4.5M →
Buffett's metric for true cash generation. Compares revenue's conversion to actual owner value.
Earnings Per Share: $1.01 →
Net income per share. The bottom line result of all revenue after costs, taxes, and interest.
Net Income: $24.4M
What remains after all expenses. Net margin shows what percentage of revenue becomes profit.
Price/Sales Ratio Analysis
IDXG's P/S ratio of 5.8x means investors pay $5.80 for every $1 of annual revenue. A P/S between 3-10 suggests investors expect continued growth and margin expansion.
Gross Margin: Revenue Quality
Gross margin of 63.75% shows how much of IDXG's revenue remains after direct costs. High gross margins above 60% often indicate strong pricing power, brand value, or intellectual property moats.
Summary: IDXG Revenue Trend
Interpace Biosciences, Inc. (IDXG) generated $36.1M in trailing twelve-month revenue, growing at 6.65% annually — positive but below the 10% level Zyberno considers strong growth. Interpace Biosciences, Inc.'s gross margin of 63.75% is excellent for a Healthcare company — above the 60% threshold Zyberno applies to healthcare businesses where IP protection, regulatory moats, and service complexity shape gross margins, a level typically associated with strong pricing power and durable competitive advantages. For complete financial analysis, view the full IDXG stock report on Zyberno.
Frequently Asked Questions
What is IDXG's current revenue?
Interpace Biosciences, Inc.'s trailing twelve month (TTM) revenue is $36.1M, growing at 6.65% annually — positive but below the 10% level Zyberno considers strong growth.
Is IDXG's revenue growing?
Interpace Biosciences, Inc. (IDXG) generated $36.1M in trailing twelve-month revenue, growing at 6.65% annually — positive but below the 10% level Zyberno considers strong growth. Interpace Biosciences, Inc.'s gross margin of 63.75% is excellent for a Healthcare company — above the 60% threshold Zyberno applies to healthcare businesses where IP protection, regulatory moats, and service complexity shape gross margins, a level typically associated with strong pricing power and durable competitive advantages.
What is IDXG's gross margin?
Interpace Biosciences, Inc.'s gross margin of 63.75% is excellent for a Healthcare company — above the 60% threshold Zyberno applies to healthcare businesses where IP protection, regulatory moats, and service complexity shape gross margins, a level typically associated with strong pricing power and durable competitive advantages.
What is IDXG's Price/Sales ratio?
IDXG's P/S ratio is 5.8x, meaning the market values the company at 5.8 times its annual revenue.
How does revenue differ from profit?
Revenue is the total income before any expenses, while profit (net income) is what remains after all costs. IDXG's revenue is $36.1M with a net income of $24.4M, showing a net profit margin of 67.6%.
📊 Full IDXG Stock Report →
See IDXG's intrinsic value, margin of safety, DCF valuation, and complete financial analysis with 250+ metrics.
💵 IDXG Free Cash Flow →
Compare to Free Cash Flow which subtracts all capital expenditures, not just maintenance CapEx.
💰 IDXG Owner Earnings →
Compare to Buffett's Owner Earnings metric which uses maintenance CapEx instead of total capital expenditures.
📈 IDXG Earnings Per Share →
Analyze EPS trends, P/E ratio, earnings yield, and per-share profitability metrics.
🎯 IDXG Earnings Surprise (SUE) →
See whether IDXG is beating or missing its own earnings trend — Standardized Unexpected Earnings and post-earnings drift.
📊 IDXG Revenue →
Analyze revenue trends, growth rate, P/S ratio, and top-line sales performance.
💰 IDXG Net Income →
Analyze the bottom-line profit, P/E ratio, and net profit margin trends.
🔶 IDXG Operating Income →
Analyze EBIT, operating margin, and core business profitability before interest and taxes.
💜 IDXG Gross Profit →
Analyze gross margin, pricing power, and profitability before operating expenses.